Cargando…

Ferulic acid ameliorates lipopolysaccharide-induced tracheal injury via cGMP/PKGII signaling pathway

BACKGROUND: Tracheal injury is a common clinical condition that still lacks an effective therapy at present. Stimulation of epithelial sodium channel (ENaC) increases Na(+) transport, which is a driving force to keep tracheal mucosa free edema fluid during tracheal injury. Ferulic acid (FA) has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaoyong, Yu, Tong, Hou, Yapeng, Han, Aixin, Ding, Yan, Nie, Hongguang, Cui, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642995/
https://www.ncbi.nlm.nih.gov/pubmed/34863181
http://dx.doi.org/10.1186/s12931-021-01897-4
_version_ 1784609788397617152
author Xie, Xiaoyong
Yu, Tong
Hou, Yapeng
Han, Aixin
Ding, Yan
Nie, Hongguang
Cui, Yong
author_facet Xie, Xiaoyong
Yu, Tong
Hou, Yapeng
Han, Aixin
Ding, Yan
Nie, Hongguang
Cui, Yong
author_sort Xie, Xiaoyong
collection PubMed
description BACKGROUND: Tracheal injury is a common clinical condition that still lacks an effective therapy at present. Stimulation of epithelial sodium channel (ENaC) increases Na(+) transport, which is a driving force to keep tracheal mucosa free edema fluid during tracheal injury. Ferulic acid (FA) has been proved to be effective in many respiratory diseases through exerting anti-oxidant, anti-inflammatory, and anti-thrombotic effects. However, these studies rarely involve the level of ion transport, especially ENaC. METHODS: C57BL/J male mice were treated intraperitoneally with normal saline or FA (100 mg/kg) 12 h before, and 12 h after intratracheal administration of lipopolysaccharide (LPS, 5 mg/kg), respectively. The effects of FA on tracheal injury were not only assessed through HE staining, immunofluorescence assay, and protein/mRNA expressions of ENaC located on tracheas, but also evaluated by the function of ENaC in mouse tracheal epithelial cells (MTECs). Besides, to explore the detailed mechanism about FA involved in LPS-induced tracheal injury, the content of cyclic guanosine monophosphate (cGMP) was measured, and Rp-cGMP (cGMP inhibitor) or cGMP-dependent protein kinase II (PKGII)-siRNA (siPKGII) were applied in primary MTECs, respectively. RESULTS: Histological examination results demonstrated that tracheal injury was obviously attenuated by pretreatment of FA. Meanwhile, FA could reverse LPS-induced reduction of both protein/mRNA expressions and ENaC activity. ELISA assay verified cGMP content was increased by FA, and administration of Rp-cGMP or transfection of siPKGII could reverse the FA up-regulated ENaC protein expression in MTECs. CONCLUSIONS: Ferulic acid can attenuate LPS-induced tracheal injury through up-regulation of ENaC at least partially via the cGMP/PKGII pathway, which may provide a promising new direction for preventive and therapeutic strategy in tracheal injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-021-01897-4.
format Online
Article
Text
id pubmed-8642995
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86429952021-12-06 Ferulic acid ameliorates lipopolysaccharide-induced tracheal injury via cGMP/PKGII signaling pathway Xie, Xiaoyong Yu, Tong Hou, Yapeng Han, Aixin Ding, Yan Nie, Hongguang Cui, Yong Respir Res Research BACKGROUND: Tracheal injury is a common clinical condition that still lacks an effective therapy at present. Stimulation of epithelial sodium channel (ENaC) increases Na(+) transport, which is a driving force to keep tracheal mucosa free edema fluid during tracheal injury. Ferulic acid (FA) has been proved to be effective in many respiratory diseases through exerting anti-oxidant, anti-inflammatory, and anti-thrombotic effects. However, these studies rarely involve the level of ion transport, especially ENaC. METHODS: C57BL/J male mice were treated intraperitoneally with normal saline or FA (100 mg/kg) 12 h before, and 12 h after intratracheal administration of lipopolysaccharide (LPS, 5 mg/kg), respectively. The effects of FA on tracheal injury were not only assessed through HE staining, immunofluorescence assay, and protein/mRNA expressions of ENaC located on tracheas, but also evaluated by the function of ENaC in mouse tracheal epithelial cells (MTECs). Besides, to explore the detailed mechanism about FA involved in LPS-induced tracheal injury, the content of cyclic guanosine monophosphate (cGMP) was measured, and Rp-cGMP (cGMP inhibitor) or cGMP-dependent protein kinase II (PKGII)-siRNA (siPKGII) were applied in primary MTECs, respectively. RESULTS: Histological examination results demonstrated that tracheal injury was obviously attenuated by pretreatment of FA. Meanwhile, FA could reverse LPS-induced reduction of both protein/mRNA expressions and ENaC activity. ELISA assay verified cGMP content was increased by FA, and administration of Rp-cGMP or transfection of siPKGII could reverse the FA up-regulated ENaC protein expression in MTECs. CONCLUSIONS: Ferulic acid can attenuate LPS-induced tracheal injury through up-regulation of ENaC at least partially via the cGMP/PKGII pathway, which may provide a promising new direction for preventive and therapeutic strategy in tracheal injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-021-01897-4. BioMed Central 2021-12-04 2021 /pmc/articles/PMC8642995/ /pubmed/34863181 http://dx.doi.org/10.1186/s12931-021-01897-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xie, Xiaoyong
Yu, Tong
Hou, Yapeng
Han, Aixin
Ding, Yan
Nie, Hongguang
Cui, Yong
Ferulic acid ameliorates lipopolysaccharide-induced tracheal injury via cGMP/PKGII signaling pathway
title Ferulic acid ameliorates lipopolysaccharide-induced tracheal injury via cGMP/PKGII signaling pathway
title_full Ferulic acid ameliorates lipopolysaccharide-induced tracheal injury via cGMP/PKGII signaling pathway
title_fullStr Ferulic acid ameliorates lipopolysaccharide-induced tracheal injury via cGMP/PKGII signaling pathway
title_full_unstemmed Ferulic acid ameliorates lipopolysaccharide-induced tracheal injury via cGMP/PKGII signaling pathway
title_short Ferulic acid ameliorates lipopolysaccharide-induced tracheal injury via cGMP/PKGII signaling pathway
title_sort ferulic acid ameliorates lipopolysaccharide-induced tracheal injury via cgmp/pkgii signaling pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642995/
https://www.ncbi.nlm.nih.gov/pubmed/34863181
http://dx.doi.org/10.1186/s12931-021-01897-4
work_keys_str_mv AT xiexiaoyong ferulicacidameliorateslipopolysaccharideinducedtrachealinjuryviacgmppkgiisignalingpathway
AT yutong ferulicacidameliorateslipopolysaccharideinducedtrachealinjuryviacgmppkgiisignalingpathway
AT houyapeng ferulicacidameliorateslipopolysaccharideinducedtrachealinjuryviacgmppkgiisignalingpathway
AT hanaixin ferulicacidameliorateslipopolysaccharideinducedtrachealinjuryviacgmppkgiisignalingpathway
AT dingyan ferulicacidameliorateslipopolysaccharideinducedtrachealinjuryviacgmppkgiisignalingpathway
AT niehongguang ferulicacidameliorateslipopolysaccharideinducedtrachealinjuryviacgmppkgiisignalingpathway
AT cuiyong ferulicacidameliorateslipopolysaccharideinducedtrachealinjuryviacgmppkgiisignalingpathway